Dyslipidemia-associated natural IgM improves oncolytic virus TILT-123 efficacy through antibody-dependent enhancement in solid tumors
Author:
James Hugo Armstrong Clubb,Santeri Artturi Pakola,Sakari Joenväärä,Tatiana Viktorovna Kudling,Tiialotta Tohmola,Victor Arias,Elise Jirovec,Mirte van der Heijden,Dafne Carolina Alves Quixabeira,Annukka Pasanen,Lyna Haybout,Nea Ojala,Saru Basnet et al.
Publication:
Molecular Therapy
© 2026 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.